BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 12890739)

  • 1. Emerging roles of BRCA1 alternative splicing.
    Orban TI; Olah E
    Mol Pathol; 2003 Aug; 56(4):191-7. PubMed ID: 12890739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families.
    Valarmathi MT; Sawhney M; Deo SSV; Shukla NK; Das SN
    Hum Mutat; 2004 Feb; 23(2):205. PubMed ID: 14722926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain.
    Campos B; Díez O; Domènech M; Baena M; Balmaña J; Sanz J; Ramírez A; Alonso C; Baiget M
    Hum Mutat; 2003 Oct; 22(4):337. PubMed ID: 12955719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case Report of Germline Compound Heterozygous Mutations in the
    Kwong A; Ho CYS; Shin VY; Au CH; Chan TL; Ma ESK
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing of breast cancer associated gene BRCA1 from breast cancer cell line.
    Lixia M; Zhijian C; Chao S; Chaojiang G; Congyi Z
    J Biochem Mol Biol; 2007 Jan; 40(1):15-21. PubMed ID: 17244477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1: what do we know? What do we think we know? What do we really need to know?
    Buller RE
    Gynecol Oncol; 2000 Mar; 76(3):291-3. PubMed ID: 10684698
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines.
    Orban TI; Olah E
    Biochem Biophys Res Commun; 2001 Jan; 280(1):32-8. PubMed ID: 11162473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation in BRCA1.
    Southey MC; Tesoriero A; Young MA; Holloway AJ; Jenkins MA; Whitty J; Misfud S; kConFab ; McLachlan SA; Venter DJ; Armes JE
    Hum Mutat; 2003 Jul; 22(1):86-91. PubMed ID: 12815598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
    Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
    Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients.
    Sanz DJ; Acedo A; Infante M; Durán M; Pérez-Cabornero L; Esteban-Cardeñosa E; Lastra E; Pagani F; Miner C; Velasco EA
    Clin Cancer Res; 2010 Mar; 16(6):1957-67. PubMed ID: 20215541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
    Riedlova P; Janoutova J; Hermanova B
    Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of BRCA1, TP53, and TSG101 germline mutations in German breast and/or ovarian cancer families.
    Balz V; Prisack HB; Bier H; Bojar H
    Cancer Genet Cytogenet; 2002 Oct; 138(2):120-7. PubMed ID: 12505256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population.
    Grzybowska E; Siemińska M; Zientek H; Kalinowska E; Michalska J; Utracka-Hutka B; Rogozińska-Szczepka J; Kaźmierczak-Maciejewska M
    Acta Biochim Pol; 2002; 49(2):351-6. PubMed ID: 12362976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins.
    Maniccia AW; Lewis C; Begum N; Xu J; Cui J; Chipitsyna G; Aysola K; Reddy V; Bhat G; Fujimura Y; Henderson B; Reddy ES; Rao VN
    J Cell Physiol; 2009 Jun; 219(3):634-41. PubMed ID: 19170108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
    Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
    Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.
    Welcsh PL; King MC
    Hum Mol Genet; 2001 Apr; 10(7):705-13. PubMed ID: 11257103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1: the enigma of tissue-specific tumor development.
    Monteiro AN
    Trends Genet; 2003 Jun; 19(6):312-5. PubMed ID: 12801723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 in breast and ovarian cancer predisposition.
    Billack B; Monteiro AN
    Cancer Lett; 2005 Sep; 227(1):1-7. PubMed ID: 16051027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.